Black Belt Therapeutics Limited
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Black Belt Therapeutics Limited
Deal Watch: Allergan Keeps After Hair Loss With Exicure Deal
Allergan has tried to go after alopecia in the past; Exicure brings a new spherical nucleic acid (SNA) technology. In other recent deals, AstraZeneca sells Seroquel, Losec rights to Germany’s Cheplapharm.
Cellular Stress Targeted By Black Belt TX-Praxis Biotech Partnership
A strategic partnership active in the hot area of understanding the tumor micro-environment in order to develop new cancer drugs has been formed by two new biotechs, the UK’s Black Belt TX and the US’s Praxis Biotech.
Start-Up Quarterly Statistics: Q3 Financings Slump Despite Large Gossamer Series B, Big Rubius IPO
Third quarter biopharma start-up financing activity decreased from the record-breaking Q2. A review of biopharma start-up dealmaking and financing activity from July through September 2018, based on data from Strategic Transactions.
Company Information
- Industry
-
Laboratory Testing Services
- Esoteric Laboratories
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice